| scholarly article | Q13442814 |
| P2093 | author name string | S B Calderwood | |
| E T Ryan | |||
| R N Smith | |||
| P A Carroll | |||
| J R Butterton | |||
| T I Crean | |||
| P2860 | cites work | Clostridium difficile: its disease and toxins | Q24617347 |
| Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro | Q24651060 | ||
| Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 | ||
| Molecular characterization of the Clostridium difficile toxin A gene | Q24656092 | ||
| Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection | Q24676013 | ||
| Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B | Q24682858 | ||
| Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development | Q28485732 | ||
| Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype | Q30420490 | ||
| TolC, an Escherichia coli outer membrane protein required for hemolysin secretion. | Q33644353 | ||
| Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis | Q33749862 | ||
| Release of a chimeric protein into the medium from Escherichia coli using the C-terminal secretion signal of haemolysin | Q33929641 | ||
| Duration of infection-derived immunity to cholera | Q70831304 | ||
| Duplication and amplification of toxin genes in Vibrio cholerae | Q71063547 | ||
| Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains | Q72746081 | ||
| Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory | Q34225394 | ||
| Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin | Q34880915 | ||
| Heterologous antigen expression in Vibrio cholerae vector strains | Q35423953 | ||
| Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD 103-HgR. | Q35777337 | ||
| Studies with Vibrio cholerae in the ligated loop of the rabbit intestine | Q36152434 | ||
| CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. | Q36262564 | ||
| Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. | Q36364180 | ||
| Effect of iron limitation on growth, siderophore production, and expression of outer membrane proteins of Vibrio cholerae | Q36384898 | ||
| Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon | Q36492515 | ||
| Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A | Q36946424 | ||
| Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y | Q36958780 | ||
| Identification of p60 antibodies in human sera and presentation of this listerial antigen on the surface of attenuated salmonellae by the HlyB-HlyD secretion system | Q36972525 | ||
| Determinants of immunogenicity and mechanisms of protection by virulent and mutant Vibrio cholerae O1 in rabbits | Q36992532 | ||
| Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters | Q37008939 | ||
| Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc | Q37025852 | ||
| Role of cholera toxin in enteric colonization by Vibrio cholerae O1 in rabbits | Q37031718 | ||
| Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1. | Q37107796 | ||
| Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholerae | Q37395794 | ||
| Salmonella strain secreting active listeriolysin changes its intracellular localization. | Q39823317 | ||
| Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR. | Q39824053 | ||
| Transport of hemolysin across the outer membrane of Escherichia coli requires two functions | Q39975513 | ||
| Antigenic cross-reactivity and functional inhibition by antibodies to Clostridium difficile toxin A, Streptococcus mutans glucan-binding protein, and a synthetic peptide | Q40151748 | ||
| Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A. | Q40153023 | ||
| Nucleotide sequence of Clostridium difficile toxin A. | Q40515226 | ||
| Clostridium difficile colitis | Q40679117 | ||
| Clostridium difficile diarrhea: pathogenesis, epidemiology, and treatment | Q40685731 | ||
| Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. | Q40762647 | ||
| Nosocomial acquisition of Clostridium difficile infection | Q41877583 | ||
| Genetic fusion of a non-toxic heat-stable enterotoxin-related decapeptide antigen to cholera toxin B-subunit | Q41877655 | ||
| Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases | Q42631108 | ||
| Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment | Q43325209 | ||
| Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding | Q43808227 | ||
| Synthesis in Vibrio cholerae and secretion of hepatitis B virus antigens fused to Escherichia coli heat-labile enterotoxin subunit B. | Q44726634 | ||
| An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: export of Shiga-like toxin IIeB subunit by Salmonella typhimurium aroA. | Q47960715 | ||
| Insertion of a HIV-1-neutralizing epitope in a surface-exposed internal region of the cholera toxin B-subunit | Q54191083 | ||
| Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. | Q54378370 | ||
| Change in the cellular localization of alkaline phosphatase by alteration of its carboxy-terminal sequence. | Q54702999 | ||
| Analysis of the haemolysin secretion system by PhoA-HlyA fusion proteins. | Q54706314 | ||
| The carboxy-terminal region of haemolysin 2001 is required for secretion of the toxin from Escherichia coli. | Q54775082 | ||
| Development of a live, oral, attenuated vaccine against El Tor cholera | Q57924437 | ||
| Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge | Q57924808 | ||
| Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin | Q67464421 | ||
| The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and non-immune rabbits | Q69149128 | ||
| Acquisition of Clostridium difficile from the hospital environment | Q69826873 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Vibrio cholerae | Q160821 |
| attenuated vaccine | Q1810913 | ||
| Clostridium difficile | Q310543 | ||
| immunization | Q1415366 | ||
| P304 | page(s) | 2941-2949 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain | |
| P478 | volume | 65 |
| Q34484003 | A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mic |
| Q36255845 | A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters |
| Q36211064 | A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection |
| Q38208794 | Antibodies for treatment of Clostridium difficile infection |
| Q28547242 | Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A |
| Q34003042 | Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae |
| Q37427354 | Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria |
| Q35896020 | Enteric pathogens as vaccine vectors for foreign antigen delivery |
| Q34403586 | Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide |
| Q37002887 | Exploiting cholera vaccines as a versatile antigen delivery platform |
| Q33866797 | Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A. |
| Q34003489 | In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae |
| Q34000827 | In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae |
| Q36136940 | Induction of immune responses in mice after intragastric administration of Lactobacillus casei producing porcine parvovirus VP2 protein |
| Q36396899 | Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure |
| Q30307170 | Management and Prevention of Clostridium difficile-Associated Diarrhea |
| Q34006339 | Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum |
| Q34003405 | Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains |
| Q41222915 | Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B. |
| Q37036112 | Protective efficacy induced by recombinant Clostridium difficile toxin fragments |
| Q33584866 | Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity |
| Q39512161 | Recombinant Staphylococcus strains as live vectors for the induction of neutralizing anti-diphtheria toxin antisera. |
| Q35923218 | Recombinant lipoprotein-based vaccine candidates against C. difficile infections |
| Q55042601 | Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform. |
| Q34009439 | Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae |
| Q38244134 | The host immune response to Clostridium difficile infection |
| Q34832263 | The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model |
| Q35913487 | Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in mice |
| Q37386803 | Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice |
| Q40899692 | Vaccination against Clostridium difficile using toxin fragments: Observations and analysis in animal models |
| Q38196682 | Vaccines against Clostridium difficile |
Search more.